Dankulchai P., Sittiwong W., Teerasamit W.
. Feasibility and safety of definite volumetric modulated arc therapy with simultaneous integrated boost to the dominant intraprostatic lesion in patients with unfavorable intermediate to high-risk prostate cancer
. Reports of Practical Oncology and Radiotherapy.
2022.
27
(2):
260-267.
Department : Radiology
Journal Name : Reports of Practical Oncology and Radiotherapy Source : Scopus
225.
de Castro G Jr, Kudaba I, Wu YL, Lopes G, Kowalski DM, Turna HZ, Caglevic C, Zhang L, Karaszewska B, Laktionov KK, Srimuninnimit V, Bondarenko I, Kubota K, Mukherjee R, Lin J, Souza F, Mok TSK, Cho BC.
. Five-Year Outcomes With Pembrolizumab Versus Chemotherapy as First-Line Therapy in Patients With Non-Small-Cell Lung Cancer and Programmed Death Ligand-1 Tumor Proportion Score ≥ 1% in the KEYNOTE-042 Study
. J Clin Oncol.
2022.
Department : Medicine
Journal Name : J Clin Oncol Source : Pubmed
